Pharma: Eli Lilly buys psychedelics developer AtaiBeckley
—·1h
In this way, the group secures access to innovative therapies for patients for whom conventional antidepressants do not work.
Channelssemiconductors, stocksCountriesgermany, europeCategoriespharma
Open original source ↗Published
7/16/2026, 11:32:17 AM
Fetched
7/16/2026, 12:07:46 PM
Confidence
60 / 100
Relevance
35 / 100
Trust
—
Language
de